跳至主要内容
临床试验/NCT00265265
NCT00265265已完成1 期

Phase 1, Double-Blind, Placebo-Controlled Multiple Dose Assessment of Potential Interactions Between Intravenous Cocaine and Atomoxetine

National Institute on Drug Abuse (NIDA)2 个研究点 分布在 1 个国家目标入组 16 人开始时间: 2005年8月最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
已完成
入组人数
16
试验地点
2
主要终点
Cardiovascular responses

研究概览

简要总结

The purpose of this study is to assess potential interactions between intravenous (i.v.) cocaine and atomoxetine (Strattera) administered orally in four escalating doses.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Treatment
盲法
Double

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • 18-45 years of age who are not seeking treatment at the time of the study
  • Must be able to provide written informed consent
  • Must be within 20 percent of ideal body weight and weigh at least 45 kg
  • Must meet DSM0IV diagnostic criteria for cocaine abuse or dependence
  • Must currently be using cocaine as confirmed by a positive BE
  • If female and of child bearing potential, must agree to the use of birth control

排除标准

  • please contact the site directly for more information

结局指标

主要结局

Cardiovascular responses

Safety

次要结局

  • Abuse Liability
  • Mood and personality assessments
  • Cocaine craving
  • pharmacokinetic assessment
  • Psychological Effects of Cocaine

研究者

申办方类型
Nih
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Assessment of Potential Interactions Between... | 临床试验